Header Logo

Oren Schaefer

Concepts (63)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pneumonia
2
2005
281
0.220
Why?
Suppuration
1
2003
11
0.210
Why?
Mycobacterium avium Complex
1
2003
3
0.210
Why?
Mycobacterium avium-intracellulare Infection
1
2003
8
0.210
Why?
Respiratory Tract Infections
1
2003
84
0.200
Why?
Bacterial Infections
1
2003
140
0.190
Why?
Cough
1
2003
182
0.180
Why?
Complement C1 Inhibitor Protein
1
2010
1
0.090
Why?
Angioedemas, Hereditary
1
2010
1
0.090
Why?
Complement Inactivating Agents
1
2010
13
0.090
Why?
Severity of Illness Index
2
2005
1479
0.080
Why?
Mianserin
1
2005
3
0.060
Why?
Oxazolidinones
1
2005
13
0.060
Why?
Serotonin Syndrome
1
2005
9
0.060
Why?
Acetamides
1
2005
12
0.060
Why?
Citalopram
1
2005
19
0.060
Why?
Triage
1
2005
109
0.060
Why?
Urticaria
1
2004
7
0.060
Why?
Antidepressive Agents
1
2005
211
0.060
Why?
Hypothermia, Induced
1
2004
40
0.050
Why?
Cold Temperature
1
2004
51
0.050
Why?
Patient Admission
1
2005
184
0.050
Why?
Immunocompetence
1
2003
20
0.050
Why?
Bronchoscopy
1
2003
86
0.050
Why?
Aortic Valve
1
2004
173
0.050
Why?
Coronary Artery Bypass
1
2004
274
0.050
Why?
Heart Valve Prosthesis Implantation
1
2004
153
0.050
Why?
Intensive Care Units
1
2005
423
0.050
Why?
Radiography
1
2003
516
0.050
Why?
Diagnosis, Differential
1
2003
933
0.040
Why?
Middle Aged
4
2005
16310
0.040
Why?
Chronic Disease
1
2003
716
0.040
Why?
Anti-Bacterial Agents
1
2005
730
0.040
Why?
Female
5
2010
30695
0.040
Why?
Adult
3
2010
15663
0.030
Why?
Aged
3
2005
13412
0.030
Why?
Humans
6
2010
59282
0.030
Why?
Adolescent
1
2003
5822
0.020
Why?
Male
4
2010
27727
0.020
Why?
Retrospective Studies
1
2003
6071
0.020
Why?
Ultrafiltration
1
2010
13
0.020
Why?
Cross-Over Studies
1
2010
153
0.020
Why?
Infusions, Intravenous
1
2010
164
0.020
Why?
Nanotechnology
1
2010
127
0.020
Why?
Analysis of Variance
1
2010
589
0.020
Why?
Proportional Hazards Models
1
2010
674
0.020
Why?
Double-Blind Method
1
2010
715
0.020
Why?
Acute Disease
1
2010
659
0.020
Why?
Linezolid
1
2005
6
0.020
Why?
Protein Synthesis Inhibitors
1
2005
25
0.020
Why?
Drug Synergism
1
2005
132
0.020
Why?
Bone Marrow Transplantation
1
2005
138
0.020
Why?
Transplantation, Homologous
1
2005
244
0.020
Why?
Urinary Tract Infections
1
2005
80
0.010
Why?
Community-Acquired Infections
1
2005
92
0.010
Why?
Rewarming
1
2004
7
0.010
Why?
Leukemia, Myeloid, Acute
1
2005
167
0.010
Why?
Sensitivity and Specificity
1
2005
1093
0.010
Why?
Pilot Projects
1
2005
914
0.010
Why?
Child
1
2010
4173
0.010
Why?
Risk Assessment
1
2005
1920
0.010
Why?
Aged, 80 and over
1
2005
5128
0.010
Why?
United States
1
2005
7385
0.010
Why?
Schaefer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (63)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_